Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis

计划入组 177 人 · 首次发布于 2021 年 12 月 9 日

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

计划入组 145 人 · 首次发布于 2022 年 2 月 24 日

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

计划入组 436 人 · 首次发布于 2023 年 11 月 30 日

Maxingxuanfeizhike Plaster

Zhihuang Plaster

Lactobacillus plantarum

Treace Medical Concepts

United States

PLANTEX

Morocco

PLANTON GmbH

Germany

Xiaflex Meets Phase III Primary Endpoint in Plantar Fibromatosis, Setting Stage for First-Ever FDA Approval

Endo's Collagenase Clostridium Histolyticum Shows Promise in Phase 2 Plantar Fibromatosis Study

Endo Presents Collagenase Clostridium Histolyticum (CCH) Data for Plantar Fibromatosis at ASPS Conference